PP129 – Safety evaluation of cancer immunotherapy in a lung-on-chip model: the therapeutic FOLR1 targeting T Cell Bispecific antibody
Giulia Raggi, Switzerland
Source: ERS Lung Science Conference 2021
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Related content which might interest you: